• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对疫苗接种作为口蹄疫防控政策益处的认知演变:南美洲的贡献

Evolving perception on the benefits of vaccination as a foot and mouth disease control policy: contributions of South America.

作者信息

Bergmann Ingrid E, Malirat Viviana, Falczuk Abraham J

机构信息

Pan American Foot and Mouth Disease Center, (PANAFTOSA) PAHO/WHO, PO Box 589, CEP:20010-974, Rio de Janeiro, Brazil.

出版信息

Expert Rev Vaccines. 2005 Dec;4(6):903-13. doi: 10.1586/14760584.4.6.903.

DOI:10.1586/14760584.4.6.903
PMID:16372885
Abstract

Within the past decade, changes in perceptions on the benefits of vaccination as an appropriate tool to achieve complete foot and mouth disease eradication have become evident. The former negative view was derived from misconceptions, resulting mainly from the belief that vaccines are not entirely effective and that vaccination masks asymptomatic viral circulation. The advent in the 1990s of vaccination policies implemented within a strategic eradication plan in South America, and during recurrence of the disease in disease-free regions contributed towards generating more reliable and visible outcomes of vaccination programs, paving the way towards a new perception. Particularly relevant was the development and application of novel serodiagnostic approaches to assess silent viral circulation, irrespective of vaccination. The use in South America of vaccination allied to serosurveys to accompany viral clarification during eradication campaigns and after emergencies clearly established the importance of this control tool to stop the spread of viral infection. This alliance gave input to break many myths associated with the use of vaccines, including the belief that immunized carrier animals pose an epidemiologic risk. This experience launched new concepts that supported the internationally recognized status of foot and mouth disease-free regions with vaccination and the 'vaccination to live' policy as an alternative to 'stamping out'.

摘要

在过去十年中,人们对疫苗接种作为实现口蹄疫彻底根除的适当工具的益处的看法发生了明显变化。以前的负面观点源于误解,主要是因为人们认为疫苗并非完全有效,而且疫苗接种会掩盖无症状病毒传播。20世纪90年代,南美洲在战略根除计划中实施疫苗接种政策,以及在无病地区疾病复发期间实施该政策,有助于产生更可靠、更明显的疫苗接种计划成果,为新观念的形成铺平了道路。特别重要的是新型血清学诊断方法的开发和应用,这些方法用于评估无症状病毒传播,而不受疫苗接种的影响。在南美洲,疫苗接种与血清学调查相结合,在根除运动期间和紧急情况后协助病毒清除,这清楚地确立了这种控制工具对于阻止病毒感染传播的重要性。这种结合有助于打破许多与疫苗使用相关的神话,包括认为免疫的携带动物会构成流行病学风险的观念。这一经验催生了新的概念,支持了通过疫苗接种实现国际认可的无口蹄疫地区地位以及“接种疫苗以存活”政策作为“扑杀”替代方案的地位。

相似文献

1
Evolving perception on the benefits of vaccination as a foot and mouth disease control policy: contributions of South America.对疫苗接种作为口蹄疫防控政策益处的认知演变:南美洲的贡献
Expert Rev Vaccines. 2005 Dec;4(6):903-13. doi: 10.1586/14760584.4.6.903.
2
Non-capsid proteins to identify foot-and-mouth disease viral circulation in cattle irrespective of vaccination.用于识别牛群中口蹄疫病毒传播的非衣壳蛋白,无论是否接种疫苗。
Biologicals. 2005 Dec;33(4):235-9. doi: 10.1016/j.biologicals.2005.08.013. Epub 2005 Oct 28.
3
Vaccination: foot-and-mouth disease experience in South America.疫苗接种:南美洲口蹄疫情况
Dev Biol (Basel). 2004;119:273-82.
4
The use of vaccines in South American foot-and-mouth disease eradication programmes.疫苗在南美洲口蹄疫根除计划中的应用。
Dev Biol (Basel). 2004;119:33-40.
5
Vaccines and foot-and-mouth disease eradication in South America.南美洲的疫苗与口蹄疫根除
Dev Biol (Basel). 2003;114:67-77.
6
Foot-and-Mouth disease 'vaccination-to-live': possibilities and constraints.口蹄疫“接种疫苗后存活”:可能性与限制因素
Dev Biol (Basel). 2004;119:267-72.
7
Development of an inhibition ELISA test for the detection of non-capsid polyprotein 3ABC in viral suspensions destined for inactivated foot-and-mouth disease vaccines.用于检测用于灭活口蹄疫疫苗的病毒悬液中非衣壳多聚蛋白3ABC的抑制ELISA试验的开发。
Dev Biol (Basel). 2006;126:241-50; discussion 327.
8
Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.针对口蹄疫病毒的疫苗接种在7天内可提供完全的临床保护,在4天内可提供部分保护:用于紧急疫情应对。
Vaccine. 2005 Dec 30;23(50):5775-82. doi: 10.1016/j.vaccine.2005.07.043. Epub 2005 Aug 8.
9
Eradication of foot-and-mouth disease in South America.
Epidemiol Bull. 1998 Jun;19(2):14-5.
10
Vaccines and companion diagnostic tests for foot-and-mouth disease virus. An overview of the experience in South America.口蹄疫病毒疫苗及配套诊断检测。南美洲经验概述。
Dev Biol (Basel). 2003;114:59-65.

引用本文的文献

1
Redefining the "carrier" state for foot-and-mouth disease from the dynamics of virus persistence in endemically affected cattle populations.从口蹄疫在地方性流行牛群中病毒持续存在的动力学角度重新定义“载体”状态。
Sci Rep. 2016 Jul 6;6:29059. doi: 10.1038/srep29059.
2
Foot-and-mouth disease: overview of motives of disease spread and efficacy of available vaccines.口蹄疫:疾病传播动机概述及现有疫苗的效力。
J Anim Sci Technol. 2015 Apr 1;57:10. doi: 10.1186/s40781-015-0042-8. eCollection 2015.
3
Use of a standardized bovine serum panel to evaluate a multiplexed nonstructural protein antibody assay for serological surveillance of foot-and-mouth disease.
使用标准化牛血清板评估用于口蹄疫血清学监测的多重非结构蛋白抗体检测方法。
Clin Vaccine Immunol. 2007 Nov;14(11):1472-82. doi: 10.1128/CVI.00227-07. Epub 2007 Oct 3.